Use cases

What you sell decides which problem you are looking for.

An antibody fails on specificity. An instrument fails on throughput. A service is bought when a group runs out of bench. A clinical assay is replaced when it disagrees with the reference method. Researchers write each of those problems down. What changes is the words.

By what you sell

Four segments. Four kinds of problem.

Each one with a real problem we found: the researchers’ own sentence, verified against the paper.

Reagents & antibodies

Find labs whose antibody or kit is letting them down

“We also tried to validate cathepsin D expression in vivo, but we were not able to optimize the immunohistochemistry protocol due to …”

PMID 36612268 · 2022 · specificity

specificitycross-reactivitylot-to-lot variabilitybackground

See the opportunity →Instruments

Find the labs whose current instrument has hit its ceiling

“For that reason, Sanger sequencing of the ORF2 gene, which is a labor intensive and time-consuming process ( Lv et al., 2020 …”

PMID 32926893 · 2020 · throughput

throughputprecisionsensitivitysample volume

See the opportunity →CRO & CDMO services

Find the groups that need a capability they do not have in house

“While the plaque reduction neutralization test (PRNT) is considered the gold standard for determining neutralizing antibody levels to flaviviruses, the assay is …”

PMID 32532141 · 2020 · throughput

throughputsample volumestandardizationreproducibility

See the opportunity →IVD & med-tech

Find the clinical groups whose current assay or device falls short

“we found a high degree of agreement on negative results (93% specificity), but only reasonable agreement on positive results (53% sensitivity).”

PMID 31888631 · 2019 · sensitivity

accuracyspecificitysensitivityreproducibility

See the opportunity →

By who you are

The same evidence, three jobs.

Founders and CEOs

Spend your sales team’s time where there is a documented reason to talk.

The labs that publish with your method, or with a competitor’s, each with the paper that says so
A dated reason to call: a new grant, trial or tender on a lab you watch
Public prices, monthly or yearly; buy on the page or book a demo first

Sales and business development

Know who to contact, which paper to reference and what to offer, before you write the first line.

A queue sorted for your products, competitors and field; what you track or dismiss sharpens it
Contacts labelled by how we got them: verified, harvested, or inferred from a pattern
The sentence, the researcher and the paper behind every opportunity

Application scientists and product teams

See which problems researchers report with the methods your product improves, and where.

Segments by technique, instrument, product or field, built from methods sections rather than job titles
The limitations a segment reports in its own papers, as material for application notes
Exhibitors, speakers and attendees matched to profiles for the conferences you go to

Whatever you sell

Every opportunity answers the same four questions.

These are not confirmed buying intentions. They are evidence-based opportunities, grounded in what researchers have actually reported. You still find out whether the problem remains and whether your solution fits. You just don’t start from zero.

Who?
Which researcher or research group have we identified?
What problem?
What concrete challenge has the researcher documented, and where is the evidence?
Why your solution?
Why do we judge that your product or technology can address the problem?
Why reach out?
What is the concrete, scientifically relevant reason to start a conversation?

See it on your own catalogue.

Bring one product. We run the search live against the researchers you sell to and show you who described the problem it solves.

Book a demo →See the prices

The mechanics behind all four are on the platform page.

Use cases

What you sell decides which problem you are looking for.

By what you sell

Four segments. Four kinds of problem.

Each one with a real problem we found: the researchers’ own sentence, verified against the paper.

Reagents & antibodies

Find labs whose antibody or kit is letting them down

“We also tried to validate cathepsin D expression in vivo, but we were not able to optimize the immunohistochemistry protocol due to …”

PMID 36612268 · 2022 · specificity

specificitycross-reactivitylot-to-lot variabilitybackground

See the opportunity →Instruments

Find the labs whose current instrument has hit its ceiling

“For that reason, Sanger sequencing of the ORF2 gene, which is a labor intensive and time-consuming process ( Lv et al., 2020 …”

PMID 32926893 · 2020 · throughput

throughputprecisionsensitivitysample volume

See the opportunity →CRO & CDMO services

Find the groups that need a capability they do not have in house

“While the plaque reduction neutralization test (PRNT) is considered the gold standard for determining neutralizing antibody levels to flaviviruses, the assay is …”

PMID 32532141 · 2020 · throughput

throughputsample volumestandardizationreproducibility

See the opportunity →IVD & med-tech

Find the clinical groups whose current assay or device falls short

“we found a high degree of agreement on negative results (93% specificity), but only reasonable agreement on positive results (53% sensitivity).”

PMID 31888631 · 2019 · sensitivity

accuracyspecificitysensitivityreproducibility

See the opportunity →

By who you are

The same evidence, three jobs.

Founders and CEOs

Spend your sales team’s time where there is a documented reason to talk.

The labs that publish with your method, or with a competitor’s, each with the paper that says so
A dated reason to call: a new grant, trial or tender on a lab you watch
Public prices, monthly or yearly; buy on the page or book a demo first

Sales and business development

Know who to contact, which paper to reference and what to offer, before you write the first line.

A queue sorted for your products, competitors and field; what you track or dismiss sharpens it
Contacts labelled by how we got them: verified, harvested, or inferred from a pattern
The sentence, the researcher and the paper behind every opportunity

Application scientists and product teams

See which problems researchers report with the methods your product improves, and where.

Segments by technique, instrument, product or field, built from methods sections rather than job titles
The limitations a segment reports in its own papers, as material for application notes
Exhibitors, speakers and attendees matched to profiles for the conferences you go to

Whatever you sell

Every opportunity answers the same four questions.

Who?
Which researcher or research group have we identified?
What problem?
What concrete challenge has the researcher documented, and where is the evidence?
Why your solution?
Why do we judge that your product or technology can address the problem?
Why reach out?
What is the concrete, scientifically relevant reason to start a conversation?

See it on your own catalogue.

Bring one product. We run the search live against the researchers you sell to and show you who described the problem it solves.

Book a demo →See the prices

The mechanics behind all four are on the platform page.

What you sell decides which problem you are looking for.

Four segments. Four kinds of problem.

Find labs whose antibody or kit is letting them down

Find the labs whose current instrument has hit its ceiling

Find the groups that need a capability they do not have in house

Find the clinical groups whose current assay or device falls short

The same evidence, three jobs.

Spend your sales team’s time where there is a documented reason to talk.

Know who to contact, which paper to reference and what to offer, before you write the first line.

See which problems researchers report with the methods your product improves, and where.

Every opportunity answers the same four questions.

Who?

What problem?

Why your solution?

Why reach out?

See it on your own catalogue.

What you sell decides which problem you are looking for.

Four segments. Four kinds of problem.

Find labs whose antibody or kit is letting them down

Find the labs whose current instrument has hit its ceiling

Find the groups that need a capability they do not have in house

Find the clinical groups whose current assay or device falls short

The same evidence, three jobs.

Spend your sales team’s time where there is a documented reason to talk.

Know who to contact, which paper to reference and what to offer, before you write the first line.

See which problems researchers report with the methods your product improves, and where.

Every opportunity answers the same four questions.

Who?

What problem?

Why your solution?

Why reach out?

See it on your own catalogue.